✦ LIBER ✦

P-502 Outcome of patients with stage III and IV non-small cell lungcancer in Marmara University Hospital, Istanbul, Turkey

✍ Scribed by Iyikesici, M.; Yumuk, P.; Dane, F.; Ekenel, M.; Basaran, G.; Turhal, N.

Book ID: 118573407
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 148 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(05)80995-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-13 The survival characteristics of the

P-13 The survival characteristics of the stage IIIB and IV non small cell lung cancer patients in Marmara University Hospital in Istanbul, Turkey

✍ Aliustaoglu, Mehmet; Gumus, Mahmut; Yumuk, Fulden; Ekenel, Meltem; Karamanoglu, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Phase II trial of chloroquinoxaline sulf

Phase II trial of chloroquinoxaline sulfonamide (CQS) in patients with stage III and IV non-small-cell lung cancer

✍ Vincent A. Miller; James R. Rigas; William P. Tong; Janice R. Reid; Katherine M. 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 129 KB

P-438 A retrospective analysis of progno

P-438 A retrospective analysis of prognostic factors and rreatment outcomes of different chemotherapy regimens in patients with locally advanced (Stage IIIB) and metastatic (Stage IV) non-small cell lung cancer (NSCLC): A single Egyptian institution's experience

✍ Azim, H.A.; Moneim, D.A.; Kamal, N.; Raouf, M.; Kamel, Y.M. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 265 KB

P382 A randomized phase II trial of sequ

P382 A randomized phase II trial of sequential gemcitabine plusvinorelbine followed by gemcitabine plus Ifosfamide versus gemcitabine plus cisplatin in the treatment of chemonaïve patients with stage III and IV non-small cell lung cancer (NSCLC)

✍ Teodorescu, G.; Ciuleanu, T.; Grigorescu, A.; Firoiu, E.; Ruta Muresan, D. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Fractionated cyclophosphamide and back t

Fractionated cyclophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (Snccl): A randomized trial of the pediatric oncology group

✍ Brecher, Martin L.; Schwenn, Molly R.; Coppes, Max J.; Bowman, W. Paul; Link, Mi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views

## Background: The pediatric oncology group (pog) conducted a two-arm, randomized study for the treatment of children and adolescents with stage iii small, non-cleaved cell lymphoma (snccl). regimen a, based on the group's previous best treatment for this group of patients, included cyclophosphamid

PointBreak: A Randomized Phase III Study

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non-Small-Cell Lung Cancer

✍ Patel, J. D.; Socinski, M. A.; Garon, E. B.; Reynolds, C. H.; Spigel, D. R.; Ols 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 243 KB